Business · 15/05/2000Updated: 10/17/2026 · 1 min read
FDA Amends Regulatory Review Period for Neuro Cybernetic Prosthesis System
Summary
The FDA is revising a previous determination regarding the regulatory review period for the Neuro Cybernetic Prosthesis System, in response to a request from the applicant, following a review of the information submitted on January 8, 1999.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →